NORDIC BIOSITE ApS: Financial statements 2023
CVR: 30711572
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NORDIC BIOSITE ApS (CVR 30711572) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 4,413,028 and a net result of DKK 2,466,842 compared with DKK 1,766,006 the year before. That is an increase of 8.7% compared with the year before. Equity in the 2023 report amounted to DKK 3,382,428. The solvency ratio was 57%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 4,413,028
- Profit/Loss
- DKK 2,466,842
- Equity
- DKK 3,382,428
- Total Assets
- DKK 5,935,889
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 4.4 mio. | 2.5 mio. | 3.4 mio. | 2 |
| 2022 | - | 4.1 mio. | 1.8 mio. | 2.4 mio. | 2 |
| 2021 | - | 4.1 mio. | 1.2 mio. | 2.4 mio. | 3 |
| 2020 | - | 14.5 mio. | 9.3 mio. | 9.7 mio. | 3 |
| 2019 | - | 3.1 mio. | 1.3 mio. | 1.4 mio. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of June 20, 2023, Lars Olof Erhard Gisterå has joined the board of directors of NORDIC BIOSITE ApS.
As of June 20, 2023, Sune Schmølker has joined the board of directors of NORDIC BIOSITE ApS.
As of June 20, 2023, Wilhelmus Catharina Martinus van Hamond has left the board of directors of NORDIC BIOSITE ApS.
As of June 20, 2023, Sune Schmølker is registered as director of NORDIC BIOSITE ApS.
As of June 20, 2023, Lars Olof Erhard Gisterå has stepped down as director of NORDIC BIOSITE ApS.
As of June 19, 2023, Lars Olof Erhard Gisterå has left the board of directors of NORDIC BIOSITE ApS.
NORDIC BIOSITE ApS has published its annual report for 2022. Gross profit came to DKK 4,058,790, and the net result was DKK 1,766,006.
About NORDIC BIOSITE ApS
NORDIC BIOSITE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2007. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The management consists of Rasmus Valdemar Lind. The board consists of Rasmus Valdemar Lind (chair) and Claudia Maria Carolina Berron Osorno. The company is owned by Nordic Biosite AB. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 6,639,125 and a net result of DKK 1,220,258 compared with DKK 1,205,660 the year before. Equity in the 2025 report amounted to DKK 1,808,346.